WebMar 16, 2024 · IMV Inc (Nasdaq, TSX: IMV) is a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on our proprietary DPX® … WebIMV Stock 12 Months Forecast. C$25.80. ―. Based on 1 Wall Street analysts offering 12 month price targets for IMV in the last 3 months. The average price target is C$25.80 with a high forecast of C$25.80 and a low forecast of C$25.80. The average price target represents a 3482.83% change from the last price of C$0.72. Highest Price Target C ...
Did you know?
WebFeb 13, 2024 · DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass., February 13, 2024--IMV Inc. (Nasdaq: IMV; TSX: IMV) ("IMV" or the "Company"), a clinical-stage biopharmaceutical company developing a portfolio of ... WebThe TSX overall saw 3,914 price advancers against 1,403 declines and 110 unchanged. During the prior 52 weeks, IMV.TO has traded as high as $17.70 (April 18,2024) and low …
WebDec 13, 2024 · DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass., December 13, 2024--IMV Inc. (the "Corporation" or "IMV") (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of ... WebMar 29, 2024 · Get the latest stock price for IMV Inc. (IMV), plus the latest news, recent trades, charting, insider activity, and analyst ratings. ... Visit the TSX ETF Investor Centre …
WebOct 23, 2004 · Imv Inc has listed on the Toronto Stock Exchange (TSX) under the ticker IMV. A total of 7,000 shares was traded during the last trading day, with total trades of 11, while having an average volume ... WebMar 21, 2024 · TSX:IMV Debt to Equity History March 21st 2024 A Look At IMV's Liabilities . Zooming in on the latest balance sheet data, we can see that IMV had liabilities of US$9.26m due within 12 months and liabilities of US$19.3m due beyond that. On the other hand, it had cash of US$38.6m and US$1.74m worth of receivables due within a year.
WebSep 1, 2024 · DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass., September 01, 2024--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel ...
WebDec 28, 2024 · IMV Inc. (Nasdaq: IMV; TSX: IMV) (the “Company”), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and va fix oversalted soupWebDec 13, 2024 · T.IMV December 13, 2024. IMV Inc. (the “Corporation” or “IMV”) (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of … fix over plucked eyebrows with makeupWebDec 20, 2024 · DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass., December 20, 2024--IMV Inc. ("IMV" or the "Company") (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company advancing a portfolio of ... canned mushrooms badWebIMV Inc. Announces Changes to Its Board of Directors. DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass., March 27, 2024--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage … canned mushroom soup and pastaWeb0x. n/a. n/a. Market Cap. US$6.22m. IMV key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise … canned mushroom soup chicken pressure cookerWebDec 9, 2024 · About IMV Inc. (TSX: IMV) IMV Inc. is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery … canned mushrooms at walmartWebMar 27, 2024 · DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass., March 27, 2024--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies, based on its novel DPX ... fix overscan windows